16.01.2025
The second messenger cyclic guanosine monophosphate (cGMP) exerts important regulatory functions in bone growth and cardiovascular homeostasis. A research team led by IFIB researchers Moritz Lehners and Robert Feil correlated cGMP signaling with the phenotype of vascular smooth muscle cells and thereby discovered an atheroprotective mechanism that reminds of remodeling processes during bone growth.
The study was published in Nature Communications.
Publication:
Lehners M., Schmidt H, Zaldivia MTK, Stehle D, Krämer M, Peter A, Adler J, Lukowski R, Feil S, Feil R. 2025. Single-cell analysis identifies the CNP/GC-B/cGMP axis as marker and regulator of modulated VSMCs in atherosclerosis. Nat Commun 16, 429 (2025). DOI: 10.1038/s41467-024-55687-9
For further information, please see the press release.
Contact:
Dr. Moritz Lehners
University of Tübingen
Interfaculty Institute of Biochemistry (IFIB)
Phone +49 7071 29-72458
moritz.lehnersspam prevention@uni-tuebingen.de